CJ Bioscience Inc Intrinsic Valuation and Fundamental Analysis - CJ Bioscience Inc - Alpha Spread
C

CJ Bioscience Inc
KOSDAQ:311690

Watchlist Manager
CJ Bioscience Inc
KOSDAQ:311690
Watchlist
Price: 12 000 KRW 1.1% Market Closed
Market Cap: 109.4B KRW
Have any thoughts about
CJ Bioscience Inc?
Write Note

Intrinsic Value

CJ Bioscience Inc's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CJ Bioscience Inc stock under the Base Case scenario is 1 342.63 KRW. Compared to the current market price of 12 000 KRW, CJ Bioscience Inc is Overvalued by 89%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
1 342.63 KRW
Overvaluation 89%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation Backtest
CJ Bioscience Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CJ Bioscience Inc based on its intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?
How do you feel about CJ Bioscience Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about CJ Bioscience Inc

Provide an overview of the primary business activities
of CJ Bioscience Inc.

What unique competitive advantages
does CJ Bioscience Inc hold over its rivals?

What risks and challenges
does CJ Bioscience Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CJ Bioscience Inc.

Provide P/S
for CJ Bioscience Inc.

Provide P/E
for CJ Bioscience Inc.

Provide P/OCF
for CJ Bioscience Inc.

Provide P/FCFE
for CJ Bioscience Inc.

Provide P/B
for CJ Bioscience Inc.

Provide EV/S
for CJ Bioscience Inc.

Provide EV/GP
for CJ Bioscience Inc.

Provide EV/EBITDA
for CJ Bioscience Inc.

Provide EV/EBIT
for CJ Bioscience Inc.

Provide EV/OCF
for CJ Bioscience Inc.

Provide EV/FCFF
for CJ Bioscience Inc.

Provide EV/IC
for CJ Bioscience Inc.

Compare the intrinsic valuations
of CJ Bioscience Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CJ Bioscience Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of CJ Bioscience Inc compared to its peers.

Compare the P/E ratios
of CJ Bioscience Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing CJ Bioscience Inc with its peers.

Analyze the financial leverage
of CJ Bioscience Inc compared to its main competitors.

Show all profitability ratios
for CJ Bioscience Inc.

Provide ROE
for CJ Bioscience Inc.

Provide ROA
for CJ Bioscience Inc.

Provide ROIC
for CJ Bioscience Inc.

Provide ROCE
for CJ Bioscience Inc.

Provide Gross Margin
for CJ Bioscience Inc.

Provide Operating Margin
for CJ Bioscience Inc.

Provide Net Margin
for CJ Bioscience Inc.

Provide FCF Margin
for CJ Bioscience Inc.

Show all solvency ratios
for CJ Bioscience Inc.

Provide D/E Ratio
for CJ Bioscience Inc.

Provide D/A Ratio
for CJ Bioscience Inc.

Provide Interest Coverage Ratio
for CJ Bioscience Inc.

Provide Altman Z-Score Ratio
for CJ Bioscience Inc.

Provide Quick Ratio
for CJ Bioscience Inc.

Provide Current Ratio
for CJ Bioscience Inc.

Provide Cash Ratio
for CJ Bioscience Inc.

What is the historical Revenue growth
over the last 5 years for CJ Bioscience Inc?

What is the historical Net Income growth
over the last 5 years for CJ Bioscience Inc?

What is the current Free Cash Flow
of CJ Bioscience Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for CJ Bioscience Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CJ Bioscience Inc

Current Assets 51.7B
Cash & Short-Term Investments 49.8B
Receivables 758.2m
Other Current Assets 1.2B
Non-Current Assets 24.1B
PP&E 10.8B
Intangibles 12.4B
Other Non-Current Assets 833.2m
Current Liabilities 14.6B
Accounts Payable 168.8m
Accrued Liabilities 3.2B
Short-Term Debt 5.1B
Other Current Liabilities 6.2B
Non-Current Liabilities 5B
Long-Term Debt 1.9B
Other Non-Current Liabilities 3.1B
Efficiency

Earnings Waterfall
CJ Bioscience Inc

Revenue
4.9B KRW
Cost of Revenue
-3.6B KRW
Gross Profit
1.3B KRW
Operating Expenses
-32.1B KRW
Operating Income
-30.8B KRW
Other Expenses
9.6B KRW
Net Income
-21.2B KRW

Free Cash Flow Analysis
CJ Bioscience Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

CJ Bioscience Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Negative 1-Year Revenue Growth
Negative 3-Years Revenue Growth
19/100
Profitability
Score

CJ Bioscience Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CJ Bioscience Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Long-Term Solvency
Low D/E
Short-Term Solvency
54/100
Solvency
Score

CJ Bioscience Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CJ Bioscience Inc

There are no price targets for CJ Bioscience Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CJ Bioscience Inc?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for CJ Bioscience Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about CJ Bioscience Inc dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

Price
CJ Bioscience Inc

1M 1M
-6%
6M 6M
-19%
1Y 1Y
-23%
3Y 3Y
-71%
5Y 5Y
-71%
10Y 10Y
-71%
Annual Price Range
12 000
52w Low
11 490
52w High
17 500
Price Metrics
Average Annual Return -6.2%
Standard Deviation of Annual Returns 34.59%
Max Drawdown -82%
Shares Statistics
Market Capitalization 109.4B KRW
Shares Outstanding 9 112 500
Percentage of Shares Shorted
N/A

Competitive Landscape

Profile

CJ Bioscience Inc

Country

Korea

Industry

Health Care

Market Cap

109.4B KRW

Dividend Yield

0%

Description

CJ Bioscience, Inc. engages in the research and development of biotechnology and in the provision of solutions for microbiological researches including biomedicine, institutional research and development and genetic sequencing. The company is headquartered in Seoul, Seoul. The company went IPO on 2019-12-26. The firm mainly provides microbial bioinformatics analysis services and microbiome-based healthcare services through bioinformatics database and cloud analytics platform. The firm also develops microbiome therapies and infection diagnosis solutions.

Contact

SEOUL
Seoul
7F, B Dong, Grand Central Tower, 14, Sejong-daero, Jung-gu
+82260783456
www.cjbioscience.com

IPO

2019-12-26

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one CJ Bioscience Inc stock?

The intrinsic value of one CJ Bioscience Inc stock under the Base Case scenario is 1 342.63 KRW.

Is CJ Bioscience Inc stock undervalued or overvalued?

Compared to the current market price of 12 000 KRW, CJ Bioscience Inc is Overvalued by 89%.

Back to Top